Cell-free DNA Screening and Maternal Cancer
( N Engl J Med . 2024;391(22):2168–2169. doi: 10.1056/NEJMe2412259) The article discusses the incidental detection of maternal cancer through cell-free DNA (cfDNA) screening, a test primarily used to identify fetal aneuploidies during pregnancy. The discussion is framed around a case study and a recent study by Turriff et al that evaluates the sensitivity of cfDNA screening in detecting cancer in pregnant individuals.
Authors
- Neil M. Vora (ORCID: https://orcid.org/0000-0002-4989-3108)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- Obstetric Anesthesia Digest
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1097/01.aoa.0001113144.95734.6b
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00